Medirom Healthcare Technologies Inc (MRM) — Strategic Asset Allocation Index
Medirom Healthcare Technologies Inc (MRM) has a Strategic Asset Allocation Index of 7.4% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $87.42 Million) total $87.42 Million, measured against net assets of $1.19 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Medirom Healthcare Technologies Inc Strategic Asset Allocation Index (2019–2024)
This chart shows how Medirom Healthcare Technologies Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2024. As of December 2024, the index stands at 7.4%, representing strategic assets of $87.42 Million against net assets of $1.19 Billion USD. Explore Medirom Healthcare Technologies Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Medirom Healthcare Technologies Inc (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Medirom Healthcare Technologies Inc from 2019 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Medirom Healthcare Technologies Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 7.4% | $87.42 Million | $- | $87.42 Million | $1.19 Billion | ▼ -30.4 pp |
| 2023 | 37.8% | $81.54 Million | $- | $81.54 Million | $215.96 Million | ▼ -332.1 pp |
| 2020 | 369.9% | $1.82 Billion | $1.81 Billion | $2.39 Million | $491.26 Million | ▲ +34.4 pp |
| 2019 | 335.5% | $2.01 Billion | $2.00 Billion | $14.04 Million | $600.06 Million | — |